Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study.
about
Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation.Silent (clinically nonfunctioning) pituitary adenomas.Non-functioning pituitary adenomas: growth and aggressiveness.Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.Silent somatotroph pituitary adenomas: an update.Management of NFAs: medical treatment.
P2860
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Treatment with octreotide LAR ...... lts from a case-control study.
@en
Treatment with octreotide LAR ...... lts from a case-control study.
@nl
type
label
Treatment with octreotide LAR ...... lts from a case-control study.
@en
Treatment with octreotide LAR ...... lts from a case-control study.
@nl
prefLabel
Treatment with octreotide LAR ...... lts from a case-control study.
@en
Treatment with octreotide LAR ...... lts from a case-control study.
@nl
P2093
P2860
P1433
P1476
Treatment with octreotide LAR ...... lts from a case-control study.
@en
P2093
Alessandra Fusco
Alfredo Pontecorvi
Anna Tofani
Antonella Giampietro
Antonio Bianchi
Carmelo Anile
Francesca Lugli
Germano Perotti
Giulio Maira
Laura De Marinis
P2860
P2888
P304
P356
10.1007/S11102-011-0370-8
P577
2012-12-01T00:00:00Z